Annual Total Liabilities
$8.36 M
-$87.83 M-91.31%
June 30, 2024
Summary
- As of February 22, 2025, MEIP annual total liabilities is $8.36 million, with the most recent change of -$87.83 million (-91.31%) on June 30, 2024.
- During the last 3 years, MEIP annual total liabilities has fallen by -$116.28 million (-93.30%).
- MEIP annual total liabilities is now -93.70% below its all-time high of $132.67 million, reached on June 30, 2020.
Performance
MEIP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.29 M
-$585.00 K-20.37%
December 31, 2024
Summary
- As of February 22, 2025, MEIP quarterly total liabilities is $2.29 million, with the most recent change of -$585.00 thousand (-20.37%) on December 31, 2024.
- Over the past year, MEIP quarterly total liabilities has dropped by -$17.94 million (-88.70%).
- MEIP quarterly total liabilities is now -98.42% below its all-time high of $144.52 million, reached on September 30, 2021.
Performance
MEIP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MEIP Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.3% | -88.7% |
| 3 y3 years | -93.3% | -88.7% |
| 5 y5 years | -76.0% | -88.7% |
MEIP Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.3% | at low | -98.3% | at low |
| 5 y | 5-year | -93.7% | at low | -98.4% | at low |
| alltime | all time | -93.7% | +2821.3% | -98.4% | +91.5% |
MEI Pharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.29 M(-20.4%) |
| Sep 2024 | - | $2.87 M(-65.6%) |
| Jun 2024 | $8.36 M(-91.3%) | $8.36 M(-58.7%) |
| Mar 2024 | - | $20.23 M(+6.2%) |
| Dec 2023 | - | $19.05 M(-4.2%) |
| Sep 2023 | - | $19.89 M(-79.3%) |
| Jun 2023 | $96.19 M(-23.3%) | $96.19 M(-3.7%) |
| Mar 2023 | - | $99.83 M(+0.6%) |
| Dec 2022 | - | $99.22 M(-21.4%) |
| Sep 2022 | - | $126.28 M(+0.7%) |
| Jun 2022 | $125.43 M(+0.6%) | $125.43 M(-0.9%) |
| Mar 2022 | - | $126.62 M(-4.2%) |
| Dec 2021 | - | $132.21 M(-8.5%) |
| Sep 2021 | - | $144.52 M(+16.0%) |
| Jun 2021 | $124.63 M(-6.1%) | $124.63 M(-11.7%) |
| Mar 2021 | - | $141.16 M(+8.3%) |
| Dec 2020 | - | $130.38 M(-1.0%) |
| Sep 2020 | - | $131.68 M(-0.7%) |
| Jun 2020 | $132.67 M(+282.0%) | $132.67 M(+499.6%) |
| Mar 2020 | - | $22.13 M(-25.8%) |
| Dec 2019 | - | $29.82 M(+37.8%) |
| Sep 2019 | - | $21.64 M(-37.7%) |
| Jun 2019 | $34.73 M(-35.9%) | $34.73 M(-27.7%) |
| Mar 2019 | - | $48.04 M(+12.2%) |
| Dec 2018 | - | $42.84 M(-22.1%) |
| Sep 2018 | - | $54.99 M(+1.5%) |
| Jun 2018 | $54.20 M(+1013.8%) | $54.20 M(+1108.7%) |
| Mar 2018 | - | $4.48 M(-13.9%) |
| Dec 2017 | - | $5.21 M(+16.7%) |
| Sep 2017 | - | $4.46 M(-8.2%) |
| Jun 2017 | $4.87 M(-11.7%) | $4.87 M(-2.5%) |
| Mar 2017 | - | $4.99 M(+50.3%) |
| Dec 2016 | - | $3.32 M(-82.3%) |
| Sep 2016 | - | $18.71 M(+239.5%) |
| Jun 2016 | $5.51 M(+11.2%) | $5.51 M(+36.9%) |
| Mar 2016 | - | $4.03 M(+19.2%) |
| Dec 2015 | - | $3.38 M(+8.0%) |
| Sep 2015 | - | $3.13 M(-36.9%) |
| Jun 2015 | $4.96 M(+7.4%) | $4.96 M(-25.3%) |
| Mar 2015 | - | $6.64 M(-3.5%) |
| Dec 2014 | - | $6.88 M(+29.7%) |
| Sep 2014 | - | $5.31 M(+15.0%) |
| Jun 2014 | $4.62 M | $4.62 M(+31.2%) |
| Mar 2014 | - | $3.52 M(+44.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $2.43 M(+65.7%) |
| Sep 2013 | - | $1.47 M(-12.5%) |
| Jun 2013 | $1.68 M(-5.6%) | $1.68 M(-6.0%) |
| Mar 2013 | - | $1.78 M(-0.8%) |
| Dec 2012 | - | $1.80 M(+10.2%) |
| Sep 2012 | - | $1.63 M(-8.1%) |
| Jun 2012 | $1.77 M(-25.3%) | $1.77 M(+18.3%) |
| Mar 2012 | - | $1.50 M(+15.7%) |
| Dec 2011 | - | $1.30 M(-18.4%) |
| Sep 2011 | - | $1.59 M(-33.1%) |
| Jun 2011 | $2.37 M(+35.3%) | $2.37 M(+27.3%) |
| Mar 2011 | - | $1.86 M(-17.6%) |
| Dec 2010 | - | $2.26 M(+20.6%) |
| Sep 2010 | - | $1.88 M(+6.9%) |
| Jun 2010 | $1.75 M(-57.6%) | $1.75 M(-23.4%) |
| Mar 2010 | - | $2.29 M(+54.1%) |
| Dec 2009 | - | $1.49 M(-40.1%) |
| Sep 2009 | - | $2.48 M(-40.1%) |
| Jun 2009 | $4.14 M(+20.3%) | $4.14 M(+55.3%) |
| Mar 2009 | - | $2.67 M(+5.2%) |
| Dec 2008 | - | $2.54 M(-11.2%) |
| Sep 2008 | - | $2.86 M(-17.0%) |
| Jun 2008 | $3.44 M(+37.0%) | $3.44 M(+5.5%) |
| Mar 2008 | - | $3.26 M(-3.1%) |
| Dec 2007 | - | $3.37 M(-2.3%) |
| Sep 2007 | - | $3.44 M(+37.0%) |
| Jun 2007 | $2.51 M(+99.4%) | $2.51 M(-0.8%) |
| Mar 2007 | - | $2.53 M(-6.7%) |
| Dec 2006 | - | $2.71 M(+127.3%) |
| Sep 2006 | - | $1.19 M(-5.2%) |
| Jun 2006 | $1.26 M(-55.7%) | $1.26 M(-65.3%) |
| Mar 2006 | - | $3.64 M(-25.0%) |
| Dec 2005 | - | $4.84 M(+25.4%) |
| Sep 2005 | - | $3.86 M(+35.9%) |
| Jun 2005 | $2.84 M(+49.1%) | $2.84 M(+49.3%) |
| Mar 2005 | - | $1.90 M(-31.7%) |
| Dec 2004 | - | $2.79 M(+31.3%) |
| Sep 2004 | - | $2.12 M(+11.4%) |
| Jun 2004 | $1.91 M(+40.9%) | $1.91 M(+34.6%) |
| Mar 2004 | - | $1.42 M(-78.8%) |
| Dec 2003 | - | $6.70 M(+287.3%) |
| Sep 2003 | - | $1.73 M(+27.8%) |
| Jun 2003 | $1.35 M(+373.1%) | $1.35 M |
| Jun 2002 | $286.00 K | - |
FAQ
- What is MEI Pharma annual total liabilities?
- What is the all time high annual total liabilities for MEI Pharma?
- What is MEI Pharma annual total liabilities year-on-year change?
- What is MEI Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for MEI Pharma?
- What is MEI Pharma quarterly total liabilities year-on-year change?
What is MEI Pharma annual total liabilities?
The current annual total liabilities of MEIP is $8.36 M
What is the all time high annual total liabilities for MEI Pharma?
MEI Pharma all-time high annual total liabilities is $132.67 M
What is MEI Pharma annual total liabilities year-on-year change?
Over the past year, MEIP annual total liabilities has changed by -$87.83 M (-91.31%)
What is MEI Pharma quarterly total liabilities?
The current quarterly total liabilities of MEIP is $2.29 M
What is the all time high quarterly total liabilities for MEI Pharma?
MEI Pharma all-time high quarterly total liabilities is $144.52 M
What is MEI Pharma quarterly total liabilities year-on-year change?
Over the past year, MEIP quarterly total liabilities has changed by -$17.94 M (-88.70%)